Cargando…
Author Correction: ENTPD1/CD39 as a predictive marker of treatment response to gemogenovatucel-T as maintenance therapy in newly diagnosed ovarian cancer
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163222/ http://dx.doi.org/10.1038/s43856-023-00290-0 |
| _version_ | 1785037841228627968 |
|---|---|
| author | Rocconi, Rodney P. Stanbery, Laura Tang, Min Madeira da Silva, Luciana Walter, Adam Monk, Bradley J. Herzog, Thomas J. Coleman, Robert L. Manning, Luisa Wallraven, Gladice Horvath, Staci Bognar, Ernest Senzer, Neil Brun, Scott Nemunaitis, John |
| author_facet | Rocconi, Rodney P. Stanbery, Laura Tang, Min Madeira da Silva, Luciana Walter, Adam Monk, Bradley J. Herzog, Thomas J. Coleman, Robert L. Manning, Luisa Wallraven, Gladice Horvath, Staci Bognar, Ernest Senzer, Neil Brun, Scott Nemunaitis, John |
| author_sort | Rocconi, Rodney P. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10163222 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101632222023-05-07 Author Correction: ENTPD1/CD39 as a predictive marker of treatment response to gemogenovatucel-T as maintenance therapy in newly diagnosed ovarian cancer Rocconi, Rodney P. Stanbery, Laura Tang, Min Madeira da Silva, Luciana Walter, Adam Monk, Bradley J. Herzog, Thomas J. Coleman, Robert L. Manning, Luisa Wallraven, Gladice Horvath, Staci Bognar, Ernest Senzer, Neil Brun, Scott Nemunaitis, John Commun Med (Lond) Author Correction Nature Publishing Group UK 2023-05-05 /pmc/articles/PMC10163222/ http://dx.doi.org/10.1038/s43856-023-00290-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Author Correction Rocconi, Rodney P. Stanbery, Laura Tang, Min Madeira da Silva, Luciana Walter, Adam Monk, Bradley J. Herzog, Thomas J. Coleman, Robert L. Manning, Luisa Wallraven, Gladice Horvath, Staci Bognar, Ernest Senzer, Neil Brun, Scott Nemunaitis, John Author Correction: ENTPD1/CD39 as a predictive marker of treatment response to gemogenovatucel-T as maintenance therapy in newly diagnosed ovarian cancer |
| title | Author Correction: ENTPD1/CD39 as a predictive marker of treatment response to gemogenovatucel-T as maintenance therapy in newly diagnosed ovarian cancer |
| title_full | Author Correction: ENTPD1/CD39 as a predictive marker of treatment response to gemogenovatucel-T as maintenance therapy in newly diagnosed ovarian cancer |
| title_fullStr | Author Correction: ENTPD1/CD39 as a predictive marker of treatment response to gemogenovatucel-T as maintenance therapy in newly diagnosed ovarian cancer |
| title_full_unstemmed | Author Correction: ENTPD1/CD39 as a predictive marker of treatment response to gemogenovatucel-T as maintenance therapy in newly diagnosed ovarian cancer |
| title_short | Author Correction: ENTPD1/CD39 as a predictive marker of treatment response to gemogenovatucel-T as maintenance therapy in newly diagnosed ovarian cancer |
| title_sort | author correction: entpd1/cd39 as a predictive marker of treatment response to gemogenovatucel-t as maintenance therapy in newly diagnosed ovarian cancer |
| topic | Author Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163222/ http://dx.doi.org/10.1038/s43856-023-00290-0 |
| work_keys_str_mv | AT rocconirodneyp authorcorrectionentpd1cd39asapredictivemarkeroftreatmentresponsetogemogenovatuceltasmaintenancetherapyinnewlydiagnosedovariancancer AT stanberylaura authorcorrectionentpd1cd39asapredictivemarkeroftreatmentresponsetogemogenovatuceltasmaintenancetherapyinnewlydiagnosedovariancancer AT tangmin authorcorrectionentpd1cd39asapredictivemarkeroftreatmentresponsetogemogenovatuceltasmaintenancetherapyinnewlydiagnosedovariancancer AT madeiradasilvaluciana authorcorrectionentpd1cd39asapredictivemarkeroftreatmentresponsetogemogenovatuceltasmaintenancetherapyinnewlydiagnosedovariancancer AT walteradam authorcorrectionentpd1cd39asapredictivemarkeroftreatmentresponsetogemogenovatuceltasmaintenancetherapyinnewlydiagnosedovariancancer AT monkbradleyj authorcorrectionentpd1cd39asapredictivemarkeroftreatmentresponsetogemogenovatuceltasmaintenancetherapyinnewlydiagnosedovariancancer AT herzogthomasj authorcorrectionentpd1cd39asapredictivemarkeroftreatmentresponsetogemogenovatuceltasmaintenancetherapyinnewlydiagnosedovariancancer AT colemanrobertl authorcorrectionentpd1cd39asapredictivemarkeroftreatmentresponsetogemogenovatuceltasmaintenancetherapyinnewlydiagnosedovariancancer AT manningluisa authorcorrectionentpd1cd39asapredictivemarkeroftreatmentresponsetogemogenovatuceltasmaintenancetherapyinnewlydiagnosedovariancancer AT wallravengladice authorcorrectionentpd1cd39asapredictivemarkeroftreatmentresponsetogemogenovatuceltasmaintenancetherapyinnewlydiagnosedovariancancer AT horvathstaci authorcorrectionentpd1cd39asapredictivemarkeroftreatmentresponsetogemogenovatuceltasmaintenancetherapyinnewlydiagnosedovariancancer AT bognarernest authorcorrectionentpd1cd39asapredictivemarkeroftreatmentresponsetogemogenovatuceltasmaintenancetherapyinnewlydiagnosedovariancancer AT senzerneil authorcorrectionentpd1cd39asapredictivemarkeroftreatmentresponsetogemogenovatuceltasmaintenancetherapyinnewlydiagnosedovariancancer AT brunscott authorcorrectionentpd1cd39asapredictivemarkeroftreatmentresponsetogemogenovatuceltasmaintenancetherapyinnewlydiagnosedovariancancer AT nemunaitisjohn authorcorrectionentpd1cd39asapredictivemarkeroftreatmentresponsetogemogenovatuceltasmaintenancetherapyinnewlydiagnosedovariancancer |